stockrowCollegium Pharmaceutical, Inc. (COLL) vs Eton Pharmaceuticals, Inc. (ETON)
- Collegium Pharmaceutical, Inc. COLL 24.27 −3.54%
- Eton Pharmaceuticals, Inc. ETON 56.22 +19.24%
Collegium Pharmaceutical, Inc. and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Eton Pharmaceuticals, Inc. is the larger, with a market value of $1.4B against $819.1M — 1.6× the size. Collegium Pharmaceutical, Inc. trades at the lower P/E: 20.0× against 31.8×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 100.6% against 7.68%. Eton Pharmaceuticals, Inc. has the higher net margin (35.4% vs 4.68%) and the higher return on invested capital (46.8% vs 6.29%). Across the 21 metrics below, Eton Pharmaceuticals, Inc. leads on 11 and Collegium Pharmaceutical, Inc. on 10.
Valuation
Profitability
| Metric | COLL | ETON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 59.05% | 69.15% | 53.51% |
| Operating margin | 15.22% | 28.84% | 0.00% |
| Net margin | 4.68% | 35.35% | (2.31%) |
| Free cash flow margin | 41.25% | 14.17% | 0.00% |
| Return on equity | 13.36% | 90.62% | (0.80%) |
| Return on assets | 2.06% | 38.10% | (1.67%) |
| Return on invested capital | 6.29% | 46.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack